消化管カテーテルの世界市場（2025年～2035年）

業界概要

世界の消化管カテーテルの市場規模は、2024年の34億米ドルから2035年には55億米ドルに達し、予測期間（2025年～2035年）のCAGRは4.5%で成長すると予測されます。消化器疾患の増加、低侵襲処置の必要性、カテーテル技術の進歩、高齢者人口の増加などが、消化管カテーテル拡大の原動力となっています。新興国のヘルスケア支出とインフラは、経腸栄養チューブに対する認識と相まって増加しています。政府の政策と規制当局の支援により、GIカテーテルの安全性と有効性が確保されています。

市場力学

技術の進歩

カテーテル技術と材料の進歩により、抗菌性表面とセンサーを搭載した柔軟で耐久性のある生体適合性医療機器が製造され、診断および治療用途の市場成長を後押ししています。例えば、2024年5月、Laborieは、消化管診断の改善のため、初の使い捨てHRAMカテーテルであるSolar Compact SystemとSolar Anorectal Manometry Catheterを発売しました。この機器は下部消化管の静的・動的圧力を記録し、排便障害や骨盤底機能障害の診断可能性を高めます。費用対効果が高く、携帯可能なソーラー・コンパクト・システムは、国際肛門生理学ワーキング・グループのプロトコルに従って、咽頭、食道、肛門の運動性試験を簡素化します。ソフトウェアは、カスタマイズ可能な手順とレポートを提供します。

増加する消化器疾患

クローン病および潰瘍性大腸炎は、消化管に慢性的な炎症と損傷をもたらし、慢性的な下痢、腹痛、体重減少などの症状を引き起こす炎症性腸疾患です。クローン病は消化管、回腸、結腸を侵します。クローン病は斑状に現れ、ある部分は侵され、他の部分はそのままになります。さらに、炎症が腸壁を突き破って広がることもあります。クローン病、GERD、大腸がんなどの消化器疾患の有病率は増加傾向にあります。クローン病・大腸炎財団によると、2024年にはクローン病や潰瘍性大腸炎を含む炎症性腸疾患（IBD）が約160万人のアメリカ人に発症し、その大半が35歳以前に診断されました。このような慢性疾患は治癒はしませんが、治療することは可能であり、患者のQOLを左右し、経済的負担も大きいです。Olmsted Countyの調査によると、米国では78万人がクローン病、90万7,000人が潰瘍性大腸炎を患っており、そのほとんどが15～35歳の間に診断されています。診断年齢の中央値は潰瘍性大腸炎が34.9歳、クローン病が29.5歳です。

市場セグメンテーション

• 製品タイプ別では、市場は経鼻胃管、経皮内視鏡的胃瘻造設術（PEG）チューブ、胃瘻チューブ（Gチューブ）、空腸瘻チューブ（Jチューブ）、胃空腸瘻チューブ（GJチューブ）、直腸カテーテル、イレウスチューブ、その他（胆道ドレナージカテーテル、ERCPカテーテル、経皮内視鏡的空腸瘻造設術（PEJ）チューブ、その他）に区分されます。
• 用途別では、市場は経腸栄養、減圧・ドレナージ、診断、治療に区分されます。
• エンドユーザー別では、病院・診療所、外来手術センター（ASC）、長期介護施設、在宅介護環境に区分されます。

経皮内視鏡的空腸瘻造設術（PEG）チューブ市場が最大シェアで市場をリード

PEGチューブは、経口摂取が不可能または十分でない場合に、長期的な栄養補給のために胃に直接栄養チューブを挿入する外科手術です。PEGチューブ、またはGチューブは、嚥下障害、栄養不足、または体内栄養処理状態の患者のための栄養チューブです。PEGチューブ挿入は、脳損傷、頭頸部がん、脳卒中、慢性食欲不振、神経障害、熱傷、嚢胞性線維症、腹部がん、遷延性昏睡、HIV/AIDSなどの病態に使用される低侵襲の処置です。PEGチューブは、経鼻胃管や腹腔鏡補助栄養法と比べて、誤嚥や苦痛のリスクを減らし、患者と介護者の生活の質を改善することで、より安全で効果的な選択肢を提供します。

診断：市場成長の主要セグメント

消化管カテーテルは、消化管障害の診断、モニタリング、治療、消化管運動の評価、異常の検出、治療介入の誘導に不可欠な医療機器です。消化管カテーテルは、食道マノメトリー、肛門十二指腸マノメトリー、大腸マノメトリー、pHおよびインピーダンスのモニタリング、栄養および経腸アクセス、内視鏡およびX線ガイドなど、さまざまな診断用途に使用されます。食道内圧のモニタリング、胃や小腸の運動機能の評価、酸逆流の検出、嚥下機能障害のある患者の栄養摂取の促進などに使用されます。さらに、造影検査や画像診断のための内視鏡的逆行性胆管膵管造影検査にも使用されます。GIカテーテルは、信頼性の高い診断情報、低侵襲検査、治療計画、長期的な消化管機能モニタリングをもたらし、適切な診断、治療計画、継続的な外来モニタリングを可能にします。

地域別展望

世界の消化管カテーテル市場は、北米（米国とカナダ）、アジア太平洋（インド、中国、日本、韓国、オーストラリア・ニュージーランド、その他）、欧州（英国、ドイツ、フランス、イタリア、スペイン、ロシア、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに分類されます。

アジア太平洋における消化管（GIT）がんの発生率の上昇

世界の消化管がん罹患率の増加は、最先端の診断・治療技術に対する需要の増加を促し、市場の成長を加速させています。インド政府の報告によると、2024年11月、IITGNの研究者はGITがんの治療プロセスを強化する新しいハイドロゲル・プラットフォームを設計しました。開発されたハイドロゲルはインド製で、内視鏡介入時に安定したクッションを形成し、正確で確実な治療を後押しします。この技術革新は、疾患対応型インテリジェント・ドラッグデリバリー・システムに革命をもたらし、患者のQOLと生存率を向上させることができます。このゲル素材はクッションのような構造を維持し、大量の水分を保持し、世界的に増加する消化管がんに対応する可能性があります。

北米が大きなシェアを占める

北米が大きなシェアを占めているのは、消化管疾患の有病率の増加により、高度な診断・治療ツールが必要とされ、特殊カテーテルの市場成長を牽引しているためです。例えば、2025年1月、QIAGENは初のQIAstat-Dxミニ消化管パネルであるQIAstat-Dx Gastrointestinal Panel 2 Mini B&V（bacterial and viral）の米国での認可を取得しました。このパネルは、カンピロバクター、サルモネラ、大腸菌様毒素（STEC）、赤痢菌、ノロウイルスなど、米国感染症学会（IDSA）が推奨する5つの胃腸疾患の原因をカバーしています。このパネルは、QIAstat-Dx Gastrointestinal Panelシリーズの臨床用第一弾であり、この重要な市場における患者の治療選択肢を改善するというQIAGENの戦略をサポートするものです。QIAstat-Dx riseの高容量装置バージョンは2025年初頭にFDAに承認申請する予定です。

最近の動向

• 2024年1月、QIAGENはインドでQIAstat-Dx装置用の2つのシンドロミック検査パネル、すなわち消化器パネル2と髄膜炎/脳炎パネルを導入しました。中央医薬品標準管理機構（CDSCO）から規制当局の承認を得たこれらのパネルは、医療従事者が患者をより良く、より早く、より簡単に診断することを可能にします。QIAstat-Dxのシステムは、コスト削減可能なカートリッジ、マルチプレックス・リアルタイムPCR、見やすいサイクル閾値レベルを採用しています。髄膜炎/脳炎パネルは、中枢神経系感染が疑われる患者において、15種類のウイルス、細菌、真菌病原体を検査します。
• 2024年8月、ATLテクノロジーはミネソタ州を拠点とし、低侵襲医療機器用の高度なカテーテル技術を専門とするMDCMソリューションズを買収しました。この買収は、ATLテクノロジーの世界事業における高度なカテーテル押出、編組、コイリング、FEP熱収縮、製品開発、プロセス認定に関するナレッジセンターとなります。
• 2024年8月、ネプチューン・メディカルは、子会社ジュピター・エンドバスキュラーが9,700万米ドルのシリーズDラウンドを終えたことを発表しました。この投資は、肺塞栓症の重要な臨床試験と、カテーテルをロボットガイドするネプチューン・メディカルのエンドポータル技術の追加臨床使用に資金を提供します。
• 2024年12月、AIG病院はEndiatxが設計したロボット内視鏡カプセル技術PillBotTを導入しましたが、インドでは臨床試験とFDAの認可待ちでした。
• 2022年8月、オブシディオはボストン・サイエンティフィックに買収されました。ボストン・サイエンティフィックは末梢血管の血管を塞栓するGEM技術を発明した民間企業で、出血を止め奇形を安定させるために採用される低侵襲の治療法です。
• 2022年3月、Guerbetはマイクロカテーテルを倍増し、新しいガイドワイヤラインを発売し、インターベンショナルイメージングと塞栓術製品の包括的ポートフォリオを提供することを目指しました。SeQureとDraKonの技術により、ナビゲーションの向上、流れに沿った塞栓術、ビーズ数の増加を実現します。
• 2022年4月、レイバーリー・メディカル・テクノロジーズは、消化器内科医、大腸外科医、インターベンショナル・ラジオロジスト向けの特殊内視鏡および傍穿刺製品のトップディストリビューターであるGIサプライを買収しました。

目次

第1章 レポート概要

• 現在の業界分析と成長ポテンシャルの展望
• 消化管カテーテルの世界市場売上分析：製品タイプ、用途、エンドユーザー
• 消化管カテーテル市場上位国の販売実績
• 調査手法
• 1次調査アプローチ
• 2次調査アプローチ
• 市場スナップショット

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 消化管カテーテル業界の主要動向
  • 市場推奨事項
• 消化管カテーテル市場のポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 新規参入業者の脅威
  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威

第3章 市場の決定要因

• 市場促進要因
  • 消化管カテーテルの世界市場における市場促進要因：影響分析
• 市場のペインポイントと課題
  • 消化管カテーテルの世界市場における市場抑制要因：影響分析
• 市場機会

第4章 競合情勢

• 競合ダッシュボード：消化管カテーテル市場の収益とシェア：メーカー別
• 消化管カテーテル製品比較分析
• 主要企業ランキングマトリックス
• 主要企業分析
  • Abbott Laboratories
  • B. Braun SE
  • Boston Scientific Corp.
  • Medtronic Inc.
  • Olympus Corp.
• 市場企業の主要成功戦略
  • 合併と買収
  • 製品発売
  • パートナーシップとコラボレーション

第5章 消化管カテーテルの世界市場売上分析：製品タイプ別

• 経鼻胃管
• 経皮内視鏡的胃瘻造設術（PEG）チューブ
• 胃瘻チューブ（Gチューブ）
• 空腸瘻チューブ（Jチューブ）
• 胃空腸瘻チューブ（GJチューブ）
• 直腸カテーテル
• イレウスチューブ
• その他（胆道ドレナージカテーテル、ERCPカテーテル、経皮内視鏡的空腸瘻造設術（PEJ）チューブ、その他）

第6章 消化管カテーテルの世界市場売上分析：用途別

• 経腸栄養
• 減圧・ドレナージ
• 診断
• 治療

第7章 消化管カテーテルの世界市場売上分析：エンドユーザー別

• 病院・診療所
• 外来手術センター（ASC）
• 長期介護施設
• 在宅介護環境

第8章 地域別分析

• 北米の消化管カテーテル市場売上分析：製品タイプ、用途、エンドユーザー、国別
• 北米のマクロ経済要因
  • 米国
  • カナダ
• 欧州の消化管カテーテル市場売上分析：製品タイプ、用途、エンドユーザー、国別
• 欧州のマクロ経済要因
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • ロシア
  • その他欧州
• アジア太平洋の消化管カテーテル市場売上分析：製品タイプ、用途、エンドユーザー、国別
• アジア太平洋のマクロ経済要因
  • 中国
  • 日本
  • 韓国
  • インド
  • オーストラリアとニュージーランド
  • ASEAN諸国（タイ、インドネシア、ベトナム、シンガポール、その他）
  • その他アジア太平洋
• 世界のその他地域の消化管カテーテル市場売上分析：製品タイプ、用途、エンドユーザー、国別
• 世界のその他地域のマクロ経済要因
  • ラテンアメリカ
  • 中東とアフリカ

第9章 企業プロファイル

• Abbott Laboratories
• Ambu A/S
• B. Braun SE
• Boston Scientific Corp.
• ConMed Corp.
• Cook Group Inc.
• Edwards Lifesciences Corp.
• Kaneka Corp.
• KARL STORZ
• Medical Measurement Systems BV
• Medtronic Inc.
• MICRO-TECH ENDOSCOPY USA INC.
• Olympus Corp.
• PENTAX Europe GmbH
• Poly Medicure Ltd.
• Stryker Corp.
• Zeon Corp.
• Zeus Company LLC

LIST OF TABLES

• 1. Global Gastrointestinal Catheters Market Research And Analysis By Product Type, 2024-2035 ($ Million)
• 2. Global Nasogastric Tubes Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 3. Global Percutaneous Endoscopic Gastrostomy (PEG) Tube Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 4. Global Gastrostomy Tubes (G-Tubes) Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 5. Global Jejunostomy Tubes (J-Tubes) Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 6. Global Gastrojejunostomy Tubes (GJ-Tubes) Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 7. Global Rectal Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 8. Global Ileus Tube Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 9. Global Other Gastrointestinal Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 10. Global Gastrointestinal Catheters Market Research And Analysis By Application, 2024-2035 ($ Million)
• 11. Global Gastrointestinal Catheters For Enteral Feeding Market Research And Analysis By Region, 2024-2035 ($ Million)
• 12. Global Gastrointestinal Catheters For Decompression and Drainage Market Research And Analysis By Region, 2024-2035 ($ Million)
• 13. Global Gastrointestinal Catheters For Diagnostics Market Research And Analysis By Region, 2024-2035 ($ Million)
• 14. Global Gastrointestinal Catheters For Therapeutic Market Research And Analysis By Region, 2024-2035 ($ Million)
• 15. Global Gastrointestinal Catheters Market Research And Analysis By End-User, 2024-2035 ($ Million)
• 16. Global Gastrointestinal Catheters For Hospitals & Clinics Market Research And Analysis By Region, 2024-2035 ($ Million)
• 17. Global Gastrointestinal Catheters For Ambulatory Surgical Centers (ASCs) Market Research And Analysis By Region, 2024-2035 ($ Million)
• 18. Global Gastrointestinal Catheters For Long-Term Care Facilities Market Research And Analysis By Region, 2024-2035 ($ Million)
• 19. Global Gastrointestinal Catheters For Home Care Settings Market Research And Analysis By Region, 2024-2035 ($ Million)
• 20. Global Gastrointestinal Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 21. North American Gastrointestinal Catheters Market Research And Analysis By Country, 2024-2035 ($ Million)
• 22. North American Gastrointestinal Catheters Market Research And Analysis By Product Type, 2024-2035 ($ Million)
• 23. North American Gastrointestinal Catheters Market Research And Analysis By Application, 2024-2035 ($ Million)
• 24. North American Gastrointestinal Catheters Market Research And Analysis By End-User, 2024-2035 ($ Million)
• 25. European Gastrointestinal Catheters Market Research And Analysis By Country, 2024-2035 ($ Million)
• 26. European Gastrointestinal Catheters Market Research And Analysis By Product Type, 2024-2035 ($ Million)
• 27. European Gastrointestinal Catheters Market Research And Analysis By Application, 2024-2035 ($ Million)
• 28. European Gastrointestinal Catheters Market Research And Analysis By End-User, 2024-2035 ($ Million)
• 29. Asia-Pacific Gastrointestinal Catheters Market Research And Analysis By Country, 2024-2035 ($ Million)
• 30. Asia-Pacific Gastrointestinal Catheters Market Research And Analysis By Product Type, 2024-2035 ($ Million)
• 31. Asia-Pacific Gastrointestinal Catheters Market Research And Analysis By Application, 2024-2035 ($ Million)
• 32. Asia-Pacific Gastrointestinal Catheters Market Research And Analysis By End-User, 2024-2035 ($ Million)
• 33. Rest Of The World Gastrointestinal Catheters Market Research And Analysis By Region, 2024-2035 ($ Million)
• 34. Rest Of The World Gastrointestinal Catheters Market Research And Analysis By Product Type, 2024-2035 ($ Million)
• 35. Rest Of The World Gastrointestinal Catheters Market Research And Analysis By Application, 2024-2035 ($ Million)
• 36. Rest Of The World Gastrointestinal Catheters Market Research And Analysis By End-User, 2024-2035 ($ Million)

LIST OF FIGURES

• 1. Global Gastrointestinal Catheters Market Research And Analysis By Product Type, 2024 Vs 2035 (%)
• 2. Global Nasogastric Tubes Catheters Market Share By Region, 2024 Vs 2035 (%)
• 3. Global Percutaneous Endoscopic Gastrostomy (PEG) Tube Catheters Market Share By Region, 2024 Vs 2035 (%)
• 4. Global Nasogastric Tubes Catheters Market Share By Region, 2024 Vs 2035 (%)
• 5. Global Gastrostomy Tubes (G-Tubes) Catheters Market Share By Region, 2024 Vs 2035 (%)
• 6. Global Jejunostomy Tubes (J-Tubes) Catheters Market Share By Region, 2024 Vs 2035 (%)
• 7. Global Gastrojejunostomy Tubes (GJ-Tubes) Catheters Market Share By Region, 2024 Vs 2035 (%)
• 8. Global Rectal Catheters Market Share By Region, 2024 Vs 2035 (%)
• 9. Global Ileus Tube Catheters Market Share By Region, 2024 Vs 2035 (%)
• 10. Global Other Type Gastrointestinal Catheters Market Share By Region, 2024 Vs 2035 (%)
• 11. Global Gastrointestinal Catheters Market Research And Analysis By Application, 2024 Vs 2035 (%)
• 12. Global Gastrointestinal Catheters For Enteral Feeding Market Share By Region, 2024 Vs 2035 (%)
• 13. Global Gastrointestinal Catheters For Decompression and Drainage Market Share By Region, 2024 Vs 2035 (%)
• 14. Global Gastrointestinal Catheters For Diagnostics Market Share By Region, 2024 Vs 2035 (%)
• 15. Global Gastrointestinal Catheters For Therapeutic Market Share By Region, 2024 Vs 2035 (%)
• 16. Global Gastrointestinal Catheters Market Research And Analysis By End-User, 2024 Vs 2035 (%)
• 17. Global Gastrointestinal Catheters For Hospitals & Clinics Market Share By Region, 2024 Vs 2035 (%)
• 18. Global Gastrointestinal Catheters For Ambulatory Surgical Centers (ASCs) Market Share By Region, 2024 Vs 2035 (%)
• 19. Global Gastrointestinal Catheters For Long-Term Care Facilities Market Share By Region, 2024 Vs 2035 (%)
• 20. Global Gastrointestinal Catheters For Home Care Settings Market Share By Region, 2024 Vs 2035 (%)
• 21. Global Gastrointestinal Catheters Market Share By Region, 2024 Vs 2035 (%)
• 22. US Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 23. Canada Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 24. UK Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 25. France Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 26. Germany Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 27. Italy Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 28. Spain Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 29. Russia Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 30. Rest Of Europe Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 31. India Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 32. China Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 33. Japan Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 34. South Korea Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 35. ASEAN Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 36. Australia and New Zealand Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 37. Rest Of Asia-Pacific Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 38. Latin America Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)
• 39. Middle East And Africa Gastrointestinal Catheters Market Size, 2024-2035 ($ Million)

Gastrointestinal Catheters Market Size, Share & Trends Analysis Report by Product Type (Nasogastric Tubes, Percutaneous Endoscopic Gastrostomy (PEG) Tube, Gastrostomy Tubes (G-Tubes), Jejunostomy Tubes (J-Tubes), Gastrojejunostomy Tubes (GJ-Tubes), Rectal Catheters, Ileus Tube, and Others), and by Application (Enteral Feeding, Decompression and Drainage, Diagnostics and Therapeutic ), and by End-User (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Long-Term Care Facilities, and Home Care Settings) Forecast Period (2025-2035)

Industry Overview

Gastrointestinal catheters market is anticipated to reach $5.5 billion in 2035 from $3.4 billion in 2024, growing at a CAGR of 4.5% during the forecast period (2025-2035). The increase in gastrointestinal diseases, the need for minimally invasive procedures, advancement in catheter technology, and the increase in the population of elderly people are all drivers of the increase in GI disorders. Healthcare expenditure and infrastructure in emerging economies are increasing, coupled with awareness of enteral feeding tubes. Government policies and regulatory support ensure the safety and efficacy of GI catheters.

Market Dynamics

Technological Advancements

Advances in catheter technology and materials have produced flexible, durable, biocompatible medical devices with antimicrobial surfaces and onboard sensors, propelling growth in the market for diagnostic and therapeutic uses. For instance, in May 2024, Laborie launched the Solar Compact System and Solar Anorectal Manometry Catheter, the first disposable HRAM catheters, for improved gastrointestinal diagnostics. The instruments record static and dynamic pressures in the lower gastrointestinal tract, increasing diagnostic potential for defecatory disorders and pelvic-floor dysfunction. The cost-effective and portable solar compact system simplifies pharyngeal, esophageal, and anorectal motility studies, following the International Anorectal Physiology Working Group protocol. The software provides customizable procedures and reports.

Rising GI Disorders

Crohn's disease and ulcerative colitis are inflammatory bowel diseases that result in chronic inflammation and damage to the gastrointestinal tract and produce symptoms such as chronic diarrhea, abdominal pain, and weight loss. Crohn's disease involves the gastrointestinal tract, the ileum, and the colon. It appears in patches, affecting some areas and leaving others untouched. Furthermore, inflammation can extend through the bowel wall. The prevalence of gastrointestinal disorders such as Crohn's disease, GERD, and colorectal cancer is on the rise. According to the Crohn's & Colitis Foundation, in 2024, inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, affected approximately 1.6 million Americans, with the majority diagnosed before age 35. The chronic conditions are not curable; however, they are treatable, influencing patients' quality of life and creating significant economic burdens. According to the Olmsted County study, 780,000 individuals in the US have Crohn's disease, and 907,000 have ulcerative colitis, most of whom are diagnosed between 15 and 35 years of age; the median age of diagnosis is 34.9 years for ulcerative colitis and 29.5 years for Crohn's disease.

Market Segmentation

• Based on the product type, the market is segmented into nasogastric tubes, percutaneous endoscopic gastrostomy (PEG) tube, gastrostomy tubes (G-Tubes), jejunostomy tubes (J-Tubes), gastrojejunostomy tubes (GJ-Tubes), rectal catheters, ileus tube, and others (biliary drainage catheter, ERCP catheter, percutaneous endoscopic jejunostomy (PEJ) tube, and other).
• Based on the application, the market is segmented into enteral feeding, decompression and drainage, diagnostics, and therapeutic.
• Based on the end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers (ASCs), long-term care facilities, and home care settings.

Percutaneous Endoscopic Gastrostomy (PEG) Tube Segment to Lead the Market with the Largest Share

A PEG tube is a surgical procedure that inserts a feeding tube directly into the stomach for long-term nutrition when oral intake is not feasible or sufficient. A PEG tube, or G-tube, is a feeding tube for patients with dysphagia, inadequate nutrition, or body nutrient processing conditions. PEG tube insertion is a minimally invasive procedure used for conditions such as brain injury, head and neck cancer, stroke, chronic loss of appetite, neurological disorders, burn, cystic fibrosis, abdominal cancer, prolonged coma, and HIV/AIDS. PEG tubes offer a safer, more effective option compared to nasogastric tubes and laparotomy-assisted feeding by decreasing the risk of aspiration, distress, and improving the quality of life of patients and caregivers.

Diagnostics: A Key Segment in Market Growth

Gastrointestinal catheters are essential medical devices for diagnosing, monitoring, and treating gastrointestinal tract disorders, evaluating gastrointestinal motility, detecting abnormalities, and guiding therapeutic intervention.GI catheters are employed in a range of diagnostic uses, such as esophageal manometry, antroduodenal manometry, colonic manometry, pH and impedance monitoring, nutritional and enteral access, and endoscopic and radiologic guidance. It is used to monitor esophageal pressure, assess stomach and small bowel motor function, detect acid reflux, and facilitate nutrition in patients with swallowing dysfunction. It further assists in contrast studies and endoscopic retrograde cholangiopancreatography for imaging and diagnostic reasons. GI catheters yield reliable diagnostic information, minimally invasive testing, treatment planning, and long-term gastrointestinal function monitoring, allowing proper diagnosis, treatment planning, and continuous ambulatory monitoring.

Regional Outlook

The global gastrointestinal catheters market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

Rising Incidence of Gastrointestinal Tract (GIT) cancers in Asia-Pacific

The increase in GIT cancer incidence across the globe has promoted increased demand for state-of-the-art diagnostic and treatment technologies, accelerating the market growth. As reported by the Indian Government, in November 2024, researchers at IITGN designed a new hydrogel platform to enhance the treatment process of GIT cancers. The hydrogel developed is made in India, and it forms a stable cushion during endoscopic interventions, boosting precise and secure treatments. This innovation can revolutionize disease-responsive intelligent drug delivery systems and enhance patient quality of life and survival. The gel material may sustain its cushion-like structure, retain high amounts of water and respond to the increase in GIT cancers globally.

North America Region Dominates the Market with Major Share

North America holds a significant share, owing to the growing prevalence of gastrointestinal disorders necessitates advanced diagnostic and therapeutic tools, driving market growth in specialized catheters. For instance, in January 2025, QIAGEN secured US clearance for its first QIAstat-Dx mini gastrointestinal panel, the QIAstat-Dx Gastrointestinal Panel 2 Mini B&V (bacterial and viral), which is designed to provide fast answers for outpatient diagnosis of gastrointestinal conditions. The panel covers five causes of gastrointestinal illness recommended by the Infectious Diseases Society of America (IDSA), such as Campylobacter, Salmonella, Shiga-like toxin E. coli (STEC), Shigella, and Norovirus. The panel is the first in a series of QIAstat-Dx Gastrointestinal Panel tests for clinical use, supporting QIAGEN's strategy to improve patient treatment options in this important market. It intends to file the QIAstat-Dx rise high-capacity instrument version for FDA approval in early 2025.

Market Players Outlook

The major companies operating in the global gastrointestinal catheters market include Abbott Laboratories, B. Braun SE, Boston Scientific Corp., Medtronic Inc., and Olympus Corp., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In January 2024, QIAGEN introduced two syndromic testing panels for its QIAstat-Dx instruments in India, namely the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel. These panels, which obtained regulatory approval from the Central Drugs Standard Control Organization (CDSCO), allow healthcare professionals to diagnose patients better, quicker, and more easily. The system of QIAstat-Dx employs cost-saving cartridges, multiplex real-time PCR, and simple-to-view cycle threshold levels. The Meningitis/Encephalitis Panel tests for 15 viral, bacterial, and fungal pathogens in patients with a suspected central nervous system infection.
• In August 2024, ATL Technology acquired MDCM Solutions, a Minnesota-based business that specializes in advanced catheter technologies for minimally invasive medical devices. The purchase is a knowledge center for advanced catheter extrusion, braiding, coiling, FEP heat shrink, product development, and process qualification for ATL Technology's global operations.
• In August 2024, Neptune Medical announced its subsidiary, Jupiter Endovascular, after a $97 million Series D round. The investment is funding a pivotal trial of pulmonary embolism and additional clinical uses of Neptune Medical's Endoportal technology that can robotically guide catheters.
• In December 2024, AIG Hospitals introduced PillBotT, a robotic endoscopy capsule technology designed by Endiatx, though clinical trials and FDA clearance were awaited in India.
• In August 2022, Obsidio was acquired by Boston Scientific, a private firm that invented GEM technology for embolization of blood vessels in peripheral vasculature, a minimally invasive intervention employed to arrest hemorrhage and stabilize malformations.
• In March 2022, Guerbet aimed to double its microcatheters and launch a new guidewire line, providing a comprehensive portfolio of interventional imaging and embolization products. SeQure and DraKon technologies deliver improved navigation, flow-directed embolization, and an increased number of beads.
• In April 2022, Laborie Medical Technologies acquired GI Supply, a top distributor of specialty endoscopy and paracentesis products for gastroenterologists, colorectal surgeons, and interventional radiologists.

The Report Covers:

• Market value data analysis for 2024 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global gastrointestinal catheters market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Global Gastrointestinal Catheters Market Sales Analysis - Product Type| Application| End-User ($ Million)
• Gastrointestinal Catheters Market Sales Performance of Top Countries
• 1.1. Research Methodology
• Primary Research Approach
• Secondary Research Approach
• 1.2. Market Snapshot

2. Market Overview and Insights

• 2.1. Scope of the Study
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Gastrointestinal Catheters Industry Trends
  • 2.2.2. Market Recommendations
• 2.3. Porter's Five Forces Analysis for the Gastrointestinal Catheters Market
  • 2.3.1. Competitive Rivalry
  • 2.3.2. Threat of New Entrants
  • 2.3.3. Bargaining Power of Suppliers
  • 2.3.4. Bargaining Power of Buyers
  • 2.3.5. Threat of Substitutes

3. Market Determinants

• 3.1. Market Drivers
  • 3.1.1. Drivers For the Global Gastrointestinal Catheters Market: Impact Analysis
• 3.2. Market Pain Points and Challenges
  • 3.2.1. Restraints For the Global Gastrointestinal Catheters Market: Impact Analysis
• 3.3. Market Opportunities

4. Competitive Landscape

• 4.1. Competitive Dashboard - Gastrointestinal Catheters Market Revenue and Share by Manufacturers
• Gastrointestinal Catheters Product Comparison Analysis
• Top Market Player Ranking Matrix
• 4.2. Key Company Analysis
  • 4.2.1. Abbott Laboratories
    • 4.2.1.1. Overview
    • 4.2.1.2. Product Portfolio
    • 4.2.1.3. Financial Analysis (Subject to Data Availability)
    • 4.2.1.4. SWOT Analysis
    • 4.2.1.5. Business Strategy
  • 4.2.2. B. Braun SE
    • 4.2.2.1. Overview
    • 4.2.2.2. Product Portfolio
    • 4.2.2.3. Financial Analysis (Subject to Data Availability)
    • 4.2.2.4. SWOT Analysis
    • 4.2.2.5. Business Strategy
  • 4.2.3. Boston Scientific Corp.
    • 4.2.3.1. Overview
    • 4.2.3.2. Product Portfolio
    • 4.2.3.3. Financial Analysis (Subject to Data Availability)
    • 4.2.3.4. SWOT Analysis
    • 4.2.3.5. Business Strategy
  • 4.2.4. Medtronic Inc.
    • 4.2.4.1. Overview
    • 4.2.4.2. Product Portfolio
    • 4.2.4.3. Financial Analysis (Subject to Data Availability)
    • 4.2.4.4. SWOT Analysis
    • 4.2.4.5. Business Strategy
  • 4.2.5. Olympus Corp.
    • 4.2.5.1. Overview
    • 4.2.5.2. Product Portfolio
    • 4.2.5.3. Financial Analysis (Subject to Data Availability)
    • 4.2.5.4. SWOT Analysis
    • 4.2.5.5. Business Strategy
• 4.3. Top Winning Strategies by Market Players
  • 4.3.1. Merger and Acquisition
  • 4.3.2. Product Launch
  • 4.3.3. Partnership And Collaboration

5. Global Gastrointestinal Catheters Market Sales Analysis by Product Type ($ Million)

• 5.1. Nasogastric Tubes
• 5.2. Percutaneous Endoscopic Gastrostomy (PEG) Tube
• 5.3. Gastrostomy Tubes (G-Tubes)
• 5.4. Jejunostomy Tubes (J-Tubes)
• 5.5. Gastrojejunostomy Tubes (GJ-Tubes)
• 5.6. Rectal Catheters
• 5.7. Ileus Tube
• 5.8. Others (Biliary Drainage Catheter, ERCP Catheter, Percutaneous Endoscopic Jejunostomy (PEJ) Tube, and Other)

6. Global Gastrointestinal Catheters Market Sales Analysis by Application ($ Million)

• 6.1. Enteral Feeding
• 6.2. Decompression and Drainage
• 6.3. Diagnostics
• 6.4. Therapeutic

7. Global Gastrointestinal Catheters Market Sales Analysis by End-User ($ Million)

• 7.1. Hospitals & Clinics
• 7.2. Ambulatory Surgical Centers (ASCs)
• 7.3. Long-Term Care Facilities
• 7.4. Home Care Settings

8. Regional Analysis

• 8.1. North American Gastrointestinal Catheters Market Sales Analysis - Product Type| Application End-User| Country ($ Million)
• Macroeconomic Factors for North America
  • 8.1.1. United States
  • 8.1.2. Canada
• 8.2. European Gastrointestinal Catheters Market Sales Analysis - Product Type| Application| End-User| Country ($ Million)
• Macroeconomic Factors for Europe
  • 8.2.1. UK
  • 8.2.2. Germany
  • 8.2.3. Italy
  • 8.2.4. Spain
  • 8.2.5. France
  • 8.2.6. Russia
  • 8.2.7. Rest of Europe
• 8.3. Asia-Pacific Gastrointestinal Catheters Market Sales Analysis - Product Type| Application| End-User| Country ($ Million)
• Macroeconomic Factors for Asia-Pacific
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
  • 8.3.4. India
  • 8.3.5. Australia & New Zealand
  • 8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Others)
  • 8.3.7. Rest of Asia-Pacific
• 8.4. Rest of the World Gastrointestinal Catheters Market Sales Analysis - Product Type| Application| End-User| Country ($ Million)
• Macroeconomic Factors for the Rest of the World
  • 8.4.1. Latin America
  • 8.4.2. Middle East and Africa

9. Company Profiles

• 9.1. Abbott Laboratories
  • 9.1.1. Quick Facts
  • 9.1.2. Company Overview
  • 9.1.3. Product Portfolio
  • 9.1.4. Business Strategies
• 9.2. Ambu A/S
  • 9.2.1. Quick Facts
  • 9.2.2. Company Overview
  • 9.2.3. Product Portfolio
  • 9.2.4. Business Strategies
• 9.3. B. Braun SE
  • 9.3.1. Quick Facts
  • 9.3.2. Company Overview
  • 9.3.3. Product Portfolio
  • 9.3.4. Business Strategies
• 9.4. Boston Scientific Corp.
  • 9.4.1. Quick Facts
  • 9.4.2. Company Overview
  • 9.4.3. Product Portfolio
  • 9.4.4. Business Strategies
• 9.5. ConMed Corp.
  • 9.5.1. Quick Facts
  • 9.5.2. Company Overview
  • 9.5.3. Product Portfolio
  • 9.5.4. Business Strategies
• 9.6. Cook Group Inc.
  • 9.6.1. Quick Facts
  • 9.6.2. Company Overview
  • 9.6.3. Product Portfolio
  • 9.6.4. Business Strategies
• 9.7. Edwards Lifesciences Corp.
  • 9.7.1. Quick Facts
  • 9.7.2. Company Overview
  • 9.7.3. Product Portfolio
  • 9.7.4. Business Strategies
• 9.8. Kaneka Corp.
  • 9.8.1. Quick Facts
  • 9.8.2. Company Overview
  • 9.8.3. Product Portfolio
  • 9.8.4. Business Strategies
• 9.9. KARL STORZ
  • 9.9.1. Quick Facts
  • 9.9.2. Company Overview
  • 9.9.3. Product Portfolio
  • 9.9.4. Business Strategies
• 9.10. Medical Measurement Systems BV
  • 9.10.1. Quick Facts
  • 9.10.2. Company Overview
  • 9.10.3. Product Portfolio
  • 9.10.4. Business Strategies
• 9.11. Medtronic Inc.
  • 9.11.1. Quick Facts
  • 9.11.2. Company Overview
  • 9.11.3. Product Portfolio
  • 9.11.4. Business Strategies
• 9.12. MICRO-TECH ENDOSCOPY USA INC.
  • 9.12.1. Quick Facts
  • 9.12.2. Company Overview
  • 9.12.3. Product Portfolio
  • 9.12.4. Business Strategies
• 9.13. Olympus Corp.
  • 9.13.1. Quick Facts
  • 9.13.2. Company Overview
  • 9.13.3. Product Portfolio
  • 9.13.4. Business Strategies
• 9.14. PENTAX Europe GmbH
  • 9.14.1. Quick Facts
  • 9.14.2. Company Overview
  • 9.14.3. Product Portfolio
  • 9.14.4. Business Strategies
• 9.15. Poly Medicure Ltd.
  • 9.15.1. Quick Facts
  • 9.15.2. Company Overview
  • 9.15.3. Product Portfolio
  • 9.15.4. Business Strategies
• 9.16. Stryker Corp.
  • 9.16.1. Quick Facts
  • 9.16.2. Company Overview
  • 9.16.3. Product Portfolio
  • 9.16.4. Business Strategies
• 9.17. Zeon Corp.
  • 9.17.1. Quick Facts
  • 9.17.2. Company Overview
  • 9.17.3. Product Portfolio
  • 9.17.4. Business Strategies
• 9.18. Zeus Company LLC
  • 9.18.1. Quick Facts
  • 9.18.2. Company Overview
  • 9.18.3. Product Portfolio
  • 9.18.4. Business Strategies